The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

NCT03173599 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: PNA 40mg
DRUG: PNA 80mg
DRUG: PNA 160mg
DRUG: PNA 240mg
DRUG: PNA 360mg
DRUG: PNA 480mg
DRUG: PNA Placebo

Sponsor

Guangzhou Yipinhong Pharmaceutical CO.,LTD